Medtronic (MDT) Depreciation & Amortization (CF) (2014 - 2026)

Medtronic has disclosed Depreciation & Amortization (CF) across 13 years of filings, most recently posting $729.0 million for Q3 2026.

• In Q3 2026, Depreciation & Amortization (CF) fell 2.54% year-over-year to $729.0 million; the TTM figure through Jul 2026 stood at $2.9 billion (changed 0.27% YoY), while the FY2026 annual figure was $3.0 billion, up 3.39% from the prior year.
• Depreciation & Amortization (CF) came in at $729.0 million for Q3 2026 at Medtronic, up from $716.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $840.0 million in Q2 2025 to a low of $649.0 million in Q1 2024.
• Average Depreciation & Amortization (CF) over 5 years is $697.5 million, with a median of $679.0 million recorded in 2023.
• Year-over-year, Depreciation & Amortization (CF) increased 28.44% in 2025 and fell 14.76% in 2026.
• Over 5 years, Depreciation & Amortization (CF) stood at $671.0 million in 2022, then advanced by 0.15% to $672.0 million in 2023, then increased by 0.45% to $675.0 million in 2024, then advanced by 10.37% to $745.0 million in 2025, then fell by 2.15% to $729.0 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $729.0 million in Q3 2026, $716.0 million in Q2 2026, and $749.0 million in Q1 2026.